Search

Your search keyword '"Lehmann che, Jacqueline"' showing total 412 results
Start Over Author "Lehmann che, Jacqueline"
412 results on '"Lehmann che, Jacqueline"'

2. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.

Author

Przanowski, Piotr, Lou, Song, Tihagam, Rachisan Djiake, Mondal, Tanmoy, Conlan, Caroline, Shivange, Gururaj, Saltani, Ilyas, Singh, Chandrajeet, Xing, Kun, Morris, Benjamin B, Mayo, Marty W, Teixeira, Luis, Lehmann-Che, Jacqueline, Tushir-Singh, Jogender, and Bhatnagar, Sanchita

Subjects
Animals, Humans, Mice, Ubiquitin-Protein Ligases, Xenograft Model Antitumor Assays, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, Female, Triple Negative Breast Neoplasms, Tripartite Motif Proteins, Genetics, Breast Cancer, Cancer, Aetiology, 2.1 Biological and endogenous factors, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

The majority of clinical deaths in patients with triple-negative breast cancer (TNBC) are due to chemoresistance and aggressive metastases, with high prevalence in younger women of African ethnicity. Although tumorigenic drivers are numerous and varied, the drivers of metastatic transition remain largely unknown. Here, we uncovered a molecular dependence of TNBC tumors on the TRIM37 network, which enables tumor cells to resist chemotherapeutic as well as metastatic stress. TRIM37-directed histone H2A monoubiquitination enforces changes in DNA repair that rendered TP53-mutant TNBC cells resistant to chemotherapy. Chemotherapeutic drugs triggered a positive feedback loop via ATM/E2F1/STAT signaling, amplifying the TRIM37 network in chemoresistant cancer cells. High expression of TRIM37 induced transcriptomic changes characteristic of a metastatic phenotype, and inhibition of TRIM37 substantially reduced the in vivo propensity of TNBC cells. Selective delivery of TRIM37-specific antisense oligonucleotides using antifolate receptor 1-conjugated nanoparticles in combination with chemotherapy suppressed lung metastasis in spontaneous metastatic murine models. Collectively, these findings establish TRIM37 as a clinically relevant target with opportunities for therapeutic intervention. SIGNIFICANCE: TRIM37 drives aggressive TNBC biology by promoting resistance to chemotherapy and inducing a prometastatic transcriptional program; inhibition of TRIM37 increases chemotherapy efficacy and reduces metastasis risk in patients with TNBC.

Published
2020

4. Enhanced expression of galectin‐9 in triple negative breast cancer cells following radiotherapy: Implications for targeted therapy.

Author

Lerévérend, Cédric, Kotaich, Nour, Cartier, Lucille, De Boni, Manon, Lahire, Sarah, Fichel, Caroline, Thiebault, Charlotte, Brabencova, Eva, Maquin, Célia, Barbosa, Elodie, Corsois, Laurent, Hotton, Judicael, Guendouzen, Sofiane, Guilbert, Philippe, Lepagnol‐Bestel, Aude‐Marie, Cahen‐Doidy, Laurence, Lehmann‐Che, Jacqueline, Devy, Jérôme, Bensussan, Armand, and Le Jan, Sébastien

Subjects
TRIPLE-negative breast cancer, BREAST cancer, TUMOR surgery, CANCER invasiveness, CANCER cells
Abstract

Optimizations are expected in the development of immunotherapy for the treatment of Triple‐negative breast cancer (TNBC). We studied the expression of galectin‐9 (Gal‐9) after irradiation and assessed the differential impacts of its targeting with or without radiotherapy. Tumor resections from TNBC patients who received neoadjuvant radiotherapy revealed higher levels of Gal‐9 in comparison to their baseline level, only in non‐responder patients. Gal‐9 expression was also found to be increased in TNBC tumor biopsies and cell lines after irradiation. We investigated the therapeutic advantage of targeting Gal‐9 after radiotherapy in mice. Irradiated 4T1 cells or control non‐irradiated 4T1 cells were injected into BALB/c mice. Anti‐Gal‐9 antibody treatment decreased tumor progression only in mice injected with irradiated 4T1 cells. This proof‐of‐concept study demonstrates that Gal‐9 could be considered as a dynamic biomarker after radiotherapy for TNBC and suggests that Gal‐9 induced‐overexpression could represent an opportunity to develop new therapeutic strategies for TNBC patients. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

5. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Author

Lehmann-Che, Jacqueline, Bally, Cécile, Letouzé, Eric, Berthier, Caroline, Yuan, Hao, Jollivet, Florence, Ades, Lionel, Cassinat, Bruno, Hirsch, Pierre, Pigneux, Arnaud, Mozziconacci, Marie-Joelle, Kogan, Scott, Fenaux, Pierre, and de Thé, Hugues

Subjects
Animals, Humans, Mice, Leukemia, Promyelocytic, Acute, Recurrence, Tretinoin, 5'-Nucleotidase, Antineoplastic Agents, Drug Resistance, Neoplasm, Mutation, Male, fms-Like Tyrosine Kinase 3, Promyelocytic Leukemia Protein, Retinoic Acid Receptor alpha, Arsenic Trioxide
Abstract

Retinoic acid (RA) and arsenic target the t(15;17)(q24;q21) PML/RARA driver of acute promyelocytic leukemia (APL), their combination now curing over 95% patients. We report exome sequencing of 64 matched samples collected from patients at initial diagnosis, during remission, and following relapse after historical combined RA-chemotherapy treatments. A first subgroup presents a high incidence of additional oncogenic mutations disrupting key epigenetic or transcriptional regulators (primarily WT1) or activating MAPK signaling at diagnosis. Relapses retain these cooperating oncogenes and exhibit additional oncogenic alterations and/or mutations impeding therapy response (RARA, NT5C2). The second group primarily exhibits FLT3 activation at diagnosis, which is lost upon relapse together with most other passenger mutations, implying that these relapses derive from ancestral pre-leukemic PML/RARA-expressing cells that survived RA/chemotherapy. Accordingly, clonogenic activity of PML/RARA-immortalized progenitors ex vivo is only transiently affected by RA, but selectively abrogated by arsenic. Our studies stress the role of cooperating oncogenes in direct relapses and suggest that targeting pre-leukemic cells by arsenic contributes to its clinical efficacy.

Published
2018

6. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Author

Eluard, Baptiste, Nuan-Aliman, Stéphanie, Faumont, Nathalie, Collares, Davi, Bordereaux, Didier, Montagne, Aurélie, Martins, Isabelle, Cagnard, Nicolas, Caly, Martial, Taoui, Oussama, Lordello, Leonardo, Lehmann-Che, Jacqueline, Tesson, Bruno, Martinez-Climent, Jose-Angel, Copie-Bergman, Christiane, Haioun, Corinne, Tilly, Hervé, Bonsang, Benjamin, Vincent-Salomon, Anne, Jais, Jean-Philippe, Jardin, Fabrice, Leroy, Karen, Maiuri, Maria Chiara, Kroemer, Guido, Molina, Thierry Jo, Feuillard, Jean, and Baud, Véronique

Published
2022
Full Text
View/download PDF

7. Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells

Author

Tran, Thi, Lavillegrand, Jean-Remi, Lereverend, Cedric, Esposito, Bruno, Cartier, Lucille, Montabord, Melanie, Tran-Rajau, Jaouen, Diedisheim, Marc, Gruel, Nadège, Ouguerram, Khadija, Paolini, Lea, Lenoir, Olivia, Pinteaux, Emmanuel, Brabencova, Eva, Tanchot, Corinne, Urquia, Pauline, Lehmann-Che, Jacqueline, Le Naour, Richard, Merrouche, Yacine, Stockmann, Christian, Mallat, Ziad, Tedgui, Alain, Ait-Oufella, Hafid, Tartour, Eric, and Potteaux, Stephane

Published
2022
Full Text
View/download PDF

9. Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors

Author

Jeschke, Jana, Collignon, Evelyne, Al Wardi, Clémence, Krayem, Mohammad, Bizet, Martin, Jia, Yan, Garaud, Soizic, Wimana, Zéna, Calonne, Emilie, Hassabi, Bouchra, Morandini, Renato, Deplus, Rachel, Putmans, Pascale, Dube, Gaurav, Singh, Nitesh Kumar, Koch, Alexander, Shostak, Kateryna, Rizzotto, Lara, Ross, Robert L., Desmedt, Christine, Bareche, Yacine, Rothé, Françoise, Lehmann-Che, Jacqueline, Duterque-Coquillaud, Martine, Leroy, Xavier, Menschaert, Gerben, Teixeira, Luis, Guo, Mingzhou, Limbach, Patrick A., Close, Pierre, Chariot, Alain, Leucci, Eleonora, Ghanem, Ghanem, Yuan, Bi-Feng, Willard-Gallo, Karen, Sotiriou, Christos, Marine, Jean-Christophe, and Fuks, François

Published
2021
Full Text
View/download PDF

10. GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors

Author

Chiche, Johanna, Reverso-Meinietti, Julie, Mouchotte, Annabelle, Rubio-Patiño, Camila, Mhaidly, Rana, Villa, Elodie, Bossowski, Jozef P., Proics, Emma, Grima-Reyes, Manuel, Paquet, Agnès, Fragaki, Konstantina, Marchetti, Sandrine, Briere, Josette, Ambrosetti, Damien, Michiels, Jean-François, Molina, Thierry Jo, Copie-Bergman, Christiane, Lehmann-Che, Jacqueline, Peyrottes, Isabelle, Peyrade, Frederic, de Kerviler, Eric, Taillan, Bruno, Garnier, Georges, Verhoeyen, Els, Paquis-Flucklinger, Véronique, Shintu, Laetitia, Delwail, Vincent, Delpech-Debiais, Celine, Delarue, Richard, Bosly, André, Petrella, Tony, Brisou, Gabriel, Nadel, Bertrand, Barbry, Pascal, Mounier, Nicolas, Thieblemont, Catherine, and Ricci, Jean-Ehrland

Published
2019
Full Text
View/download PDF

11. Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review

Author

Lamy, Pierre-Jean, Allory, Yves, Gauchez, Anne-Sophie, Asselain, Bernard, Beuzeboc, Philippe, de Cremoux, Patricia, Fontugne, Jacqueline, Georges, Agnès, Hennequin, Christophe, Lehmann-Che, Jacqueline, Massard, Christophe, Millet, Ingrid, Murez, Thibaut, Schlageter, Marie-Hélène, Rouvière, Olivier, Kassab-Chahmi, Diana, Rozet, François, Descotes, Jean-Luc, and Rébillard, Xavier

Published
2018
Full Text
View/download PDF

13. Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study)

Author

Leroy, Karen, primary, Audigier Valette, Clarisse, additional, Alexandre, Jérôme, additional, Boussemart, Lise, additional, Chiesa, Jean, additional, Deldycke, Clotilde, additional, Gomez-Rocca, Carlos, additional, Hollebecque, Antoine, additional, Lehmann-Che, Jacqueline, additional, Lemoine, Antoinette, additional, Mansard, Sandrine, additional, Medioni, Jacques, additional, Monnet, Isabelle, additional, Mourah, Samia, additional, Pierret, Thomas, additional, Spaëth, Dominique, additional, Civet, Alexandre, additional, Galoin, Sandrine, additional, and Italiano, Antoine, additional

Published
2023
Full Text
View/download PDF

14. Primary cutaneous follicle center lymphoma with secondary systemic evolution

Author

Li, Andy, primary, Lehmann-Che, Jacqueline, additional, Champ, Jérôme, additional, Rivet, Jacqueline, additional, Vignon-Pennamen, Marie-Dominique, additional, Mourah, Samia, additional, Cayuela, Jean-Michel, additional, Lepelletier, Clémence, additional, Louveau, Baptiste, additional, Dumont, Maëlle, additional, Al-Hage, Jana, additional, Ram-Wolff, Caroline, additional, Bouaziz, Jean-David, additional, Bagot, Martine, additional, De Masson, Adèle, additional, and Battistella, Maxime, additional

Published
2023
Full Text
View/download PDF

21. Supplementary Table II from Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Author

Przanowski, Piotr, primary, Lou, Song, primary, Tihagam, Rachisan Djiake, primary, Mondal, Tanmoy, primary, Conlan, Caroline, primary, Shivange, Gururaj, primary, Saltani, Ilyas, primary, Singh, Chandrajeet, primary, Xing, Kun, primary, Morris, Benjamin B., primary, Mayo, Marty W., primary, Teixeira, Luis, primary, Lehmann-Che, Jacqueline, primary, Tushir-Singh, Jogender, primary, and Bhatnagar, Sanchita, primary

Published
2023
Full Text
View/download PDF

22. Data from Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Author

Przanowski, Piotr, primary, Lou, Song, primary, Tihagam, Rachisan Djiake, primary, Mondal, Tanmoy, primary, Conlan, Caroline, primary, Shivange, Gururaj, primary, Saltani, Ilyas, primary, Singh, Chandrajeet, primary, Xing, Kun, primary, Morris, Benjamin B., primary, Mayo, Marty W., primary, Teixeira, Luis, primary, Lehmann-Che, Jacqueline, primary, Tushir-Singh, Jogender, primary, and Bhatnagar, Sanchita, primary

Published
2023
Full Text
View/download PDF

23. Supplementary figures from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Author

Leroy, Bernard, primary, Ballinger, Mandy L., primary, Baran-Marszak, Fanny, primary, Bond, Gareth L., primary, Braithwaite, Antony, primary, Concin, Nicole, primary, Donehower, Lawrence A., primary, El-Deiry, Wafik S., primary, Fenaux, Pierre, primary, Gaidano, Gianluca, primary, Langerød, Anita, primary, Hellstrom-Lindberg, Eva, primary, Iggo, Richard, primary, Lehmann-Che, Jacqueline, primary, Mai, Phuong L., primary, Malkin, David, primary, Moll, Ute M., primary, Myers, Jeffrey N., primary, Nichols, Kim E., primary, Pospisilova, Sarka, primary, Ashton-Prolla, Patricia, primary, Rossi, Davide, primary, Savage, Sharon A., primary, Strong, Louise C., primary, Tonin, Patricia N., primary, Zeillinger, Robert, primary, Zenz, Thorsten, primary, Fraumeni, Joseph F., primary, Taschner, Peter E.M., primary, Hainaut, Pierre, primary, and Soussi, Thierry, primary

Published
2023
Full Text
View/download PDF

24. Figure S2 from Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Author

Przanowski, Piotr, primary, Lou, Song, primary, Tihagam, Rachisan Djiake, primary, Mondal, Tanmoy, primary, Conlan, Caroline, primary, Shivange, Gururaj, primary, Saltani, Ilyas, primary, Singh, Chandrajeet, primary, Xing, Kun, primary, Morris, Benjamin B., primary, Mayo, Marty W., primary, Teixeira, Luis, primary, Lehmann-Che, Jacqueline, primary, Tushir-Singh, Jogender, primary, and Bhatnagar, Sanchita, primary

Published
2023
Full Text
View/download PDF

25. Data from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Author

Leroy, Bernard, primary, Ballinger, Mandy L., primary, Baran-Marszak, Fanny, primary, Bond, Gareth L., primary, Braithwaite, Antony, primary, Concin, Nicole, primary, Donehower, Lawrence A., primary, El-Deiry, Wafik S., primary, Fenaux, Pierre, primary, Gaidano, Gianluca, primary, Langerød, Anita, primary, Hellstrom-Lindberg, Eva, primary, Iggo, Richard, primary, Lehmann-Che, Jacqueline, primary, Mai, Phuong L., primary, Malkin, David, primary, Moll, Ute M., primary, Myers, Jeffrey N., primary, Nichols, Kim E., primary, Pospisilova, Sarka, primary, Ashton-Prolla, Patricia, primary, Rossi, Davide, primary, Savage, Sharon A., primary, Strong, Louise C., primary, Tonin, Patricia N., primary, Zeillinger, Robert, primary, Zenz, Thorsten, primary, Fraumeni, Joseph F., primary, Taschner, Peter E.M., primary, Hainaut, Pierre, primary, and Soussi, Thierry, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 7 from Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Author

Przanowski, Piotr, primary, Lou, Song, primary, Tihagam, Rachisan Djiake, primary, Mondal, Tanmoy, primary, Conlan, Caroline, primary, Shivange, Gururaj, primary, Saltani, Ilyas, primary, Singh, Chandrajeet, primary, Xing, Kun, primary, Morris, Benjamin B., primary, Mayo, Marty W., primary, Teixeira, Luis, primary, Lehmann-Che, Jacqueline, primary, Tushir-Singh, Jogender, primary, and Bhatnagar, Sanchita, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Data from Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Author

Coutant, Charles, primary, Rouzier, Roman, primary, Qi, Yuan, primary, Lehmann-Che, Jacqueline, primary, Bianchini, Giampaolo, primary, Iwamoto, Takayuki, primary, Hortobagyi, Gabriel N., primary, Symmans, W. Fraser, primary, Uzan, Serge, primary, Andre, Fabrice, primary, de Thé, Hugues, primary, and Pusztai, Lajos, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Data from Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Author

Przanowski, Piotr, primary, Lou, Song, primary, Tihagam, Rachisan Djiake, primary, Mondal, Tanmoy, primary, Conlan, Caroline, primary, Shivange, Gururaj, primary, Saltani, Ilyas, primary, Singh, Chandrajeet, primary, Xing, Kun, primary, Morris, Benjamin B., primary, Mayo, Marty W., primary, Teixeira, Luis, primary, Lehmann-Che, Jacqueline, primary, Tushir-Singh, Jogender, primary, and Bhatnagar, Sanchita, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table 5 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

30. Data from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 2 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

32. Data from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 6 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 2 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 3 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table 1 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Legends from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 1 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table 3 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Figure 3 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table 1 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figure 2 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure Legends 1-3 from Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Author

Janouskova, Hana, primary, Maglott, Anne, primary, Leger, David Y., primary, Bossert, Catherine, primary, Noulet, Fanny, primary, Guerin, Eric, primary, Guenot, Dominique, primary, Pinel, Sophie, primary, Chastagner, Pascal, primary, Plenat, François, primary, Entz-Werle, Natacha, primary, Lehmann-Che, Jacqueline, primary, Godet, Julien, primary, Martin, Sophie, primary, Teisinger, Jan, primary, and Dontenwill, Monique, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 4 from High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Author

Manié, Elodie, primary, Vincent-Salomon, Anne, primary, Lehmann-Che, Jacqueline, primary, Pierron, Gaelle, primary, Turpin, Elisabeth, primary, Warcoin, Mathilde, primary, Gruel, Nadège, primary, Lebigot, Ingrid, primary, Sastre-Garau, Xavier, primary, Lidereau, Rosette, primary, Remenieras, Audrey, primary, Feunteun, Jean, primary, Delattre, Olivier, primary, de Thé, Hugues, primary, Stoppa-Lyonnet, Dominique, primary, and Stern, Marc-Henri, primary

Published
2023
Full Text
View/download PDF

49. p53 in the Clinic: A Pathologist’s View

Author

Bertheau, Philippe, Fléjou, Jean-François, Allory, Yves, Varlet, Pascale, Lantuejoul, Sylvie, Plassa, Louis-François, de Thé, Hugues, Janin, Anne, Lehmann-Che, Jacqueline, Hainaut, Pierre, editor, Olivier, Magali, editor, and Wiman, Klas G., editor

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results